Norethindrone acetate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Rising Pharmaceuticals, Inc.. The primary component is Norethindrone Acetate.
Product ID | 16571-658_6c48c0f2-586b-48df-bb15-bff658a3b650 |
NDC | 16571-658 |
Product Type | Human Prescription Drug |
Proprietary Name | Norethindrone acetate |
Generic Name | Norethindrone Acetate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2018-11-05 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA206490 |
Labeler Name | Rising Pharmaceuticals, Inc. |
Substance Name | NORETHINDRONE ACETATE |
Active Ingredient Strength | 5 mg/1 |
Pharm Classes | Progesterone Congeners [CS],Progestin [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2018-11-05 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA206490 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-11-05 |
Marketing Category | ANDA |
Application Number | ANDA206490 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-11-05 |
Ingredient | Strength |
---|---|
NORETHINDRONE ACETATE | 5 mg/1 |
SPL SET ID: | 6c48c0f2-586b-48df-bb15-bff658a3b650 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0179-0227 | Norethindrone Acetate | Norethindrone Acetate |
0378-7291 | Norethindrone Acetate | Norethindrone Acetate |
0555-0211 | Norethindrone Acetate | Norethindrone Acetate |
16571-658 | Norethindrone acetate | norethindrone acetate |
42291-650 | Norethindrone Acetate | Norethindrone |
50268-602 | Norethindrone Acetate | Norethindrone |
50742-267 | Norethindrone acetate | norethindrone acetate |
65162-475 | Norethindrone Acetate | Norethindrone |
65862-715 | Norethindrone acetate | Norethindrone acetate |
68462-304 | Norethindrone Acetate | Norethindrone Acetate |
51285-424 | Aygestin | Norethindrone Acetate |